Tracking your fitness and health just got easier if you use MyFitnessPal and Google's Wear OS. The MyFitnessPal smartwatch app offers a way to keep track of your health stats, including calorie intake and gym gains. While this worked well, it has also been limited since you couldn't edit or input your data directly on your wearable device. However, the latest app update changes things for the better.

In a recent blog post, MyFitnessPal announced updates that will make tracking and logging easier on Wear OS. Now, users can track and log without pulling out their phones. When wearing compatible Android smartwatches, users will have access to new watch tiles and complications — which will give them the ability to log foods they eat regularly while keeping track of daily nutritional intake, like sugar, fiber, fats, calories and even hydration. Users will also be able to see a quick snapshot of their entire day right from their wrists.

This feature will be available to users with a smartwatch running Wear OS, like the new Pixel Watch 2. The MyFitnessPal app is available for download from the Google Play Store.

While this feature isn't entirely new to the MyFitnessPal app on smartwatches — Apple Watch users have had this option for a while — it’s good news that people using Wear OS have another way to track.  Monitoring our health and wellness is important and can be easily neglected when we just don't have the time. Any innovation, big or small, that makes keeping up with health stats easier is always a good move. Now if only they could figure out a way to burn and log calories without the exercise.

The ARC nerve stimulation therapy system from startup Onward Medical passed another developmental milestone on Wednesday, as the company announced the first successful installation of its brainwave-driven implantable electrode array to restore function and feeling to a patient’s hands and arms. The news comes just five months after the researchers implanted a similar system in a different patient to help them regain a more natural walking gait.

The ARC system used differs depending on how what issue it's being applied to. The ARC-EX is an external, non-invasive stimulator array that sits on the patient’s lower back and helps regulate their bladder control and blood pressure, as well as improving limb function and control. Onward’s lower limb study from May employed the EX along with a BCI controller from CEA-Clinatec to create a “digital bridge” spanning the gap in the patient’s spinal column.

The study published Wednesday instead utilized the ARC-IM, an implantable version of the company’s stimulator array which is installed near the spinal cord and is controlled through wearable components and a smartwatch. Onward had previously used the IM system to enable paralyzed patients to stand and walk short distances without assistance, for which it was awarded an FDA Breakthrough Device Designation in 2020.

Medical professionals led by by neurosurgeon Dr. Jocelyne Bloch, implanted the ARC-IM and the Clinatec BCI into a 46-year-old patient suffering from a C4 spinal injury, in mid-August. The BCI’s hair-thin leads pick up electrical signals in the patient’s brain, convert those analog signals into digital ones that machines can understand, and then transmits them to a nearby computing device where a machine learning AI interprets the patient’s electrical signals and issues commands to the implanted stimulator array. The patient thinks about what they want to do and these two devices work to translate that intent into computer-controlled movement.

How well that translation occurs remains to be seen while the patient learns and adapts to the new system. “The implant procedures involving the Onward ARC-IM and Clinatec BCI went smoothly,” Dr. Bloch said in an press release. “We are now working with the patient to use this cutting-edge innovation to recover movement of his arms, hands, and fingers. We look forward to sharing more information in due course.”

“If the therapy continues to show promise, it is possible it could reach patients by the end of the decade,” Onward CEO Dave Marver said in a statement to Engadget. “It is important to note that we do not expect people with spinal cord injury to wait that long for Onward to commercialize an impactful therapy - we hope to commercialize our external spinal cord stimulation solution, ARC-EX Therapy, to restore hand and arm function in the second half of 2024.”

Onward Medical among a quickly expanding field of BCI-based startups working to apply the fledgling technology to a variety of medical maladies. Those applications include loss of limb and self-regulatory function due to stroke, traumatic brain or spinal cord injury, physical rehabilitation from those same injuries, as well as a critical means of communication for people living with Locked-In Syndrome.

Apple’s watchOS 10 officially became available on September 18, and it brings a new feature in the Mindfulness app that gives you the option of logging your feelings and moods directly on your watch face. These updates will be available if you have an Apple Watch Series 4 or newer model. Here’s how to navigate that new feature.

Malak Saleh

How to log your mood

When you open the Mindfulness app, tap “State of Mind” and then “Get Started” to begin the logging process. From there, you can either log a “momentary emotion” to input how you feel at that instant, or a “daily mood” to report how you felt overall that day.

Malak Saleh

Using the watch’s Digital Crown, you can scroll through seven abstract images with corresponding emotional valences ranging from "very pleasant" to "very unpleasant." Once you select an emotion, you can opt for more logging and go into greater detail about the feelings you’re experiencing (including what's having the biggest effect on you) by selecting options from a drop-down menu.

Malak Saleh

How to view your mood logs

Over time you can keep tabs on your daily logging activity in the Health app under the “Mental Wellbeing” tab. Using a paired iPhone, click “State of Mind” and then open “Show in Charts.” From this page, you can view the type of entries for daily moods or momentary emotions. You also have the option to view lifestyle factors associated with these entries to learn how your moods may correlate with variables like time spent in the sun, sleep trends, and exercise habits.

Malak Saleh

Additionally, specific assessments for depression and anxiety are now accessible in the Health app. You can also export PDFs of personal health reports if you ever need to share logs with a medical professional. You’ll need to open the Health app and click the “Sharing tab” at the bottom of the screen. From there you can choose to “Share with someone,” such as a contact, or “Share with your doctor.” 

If you want to share with your doctor, you can search for specific hospital systems to connect your health data and keep tabs on clinical records. For example, if you were a client at “Green Primary Care” in Huntsville, Alabama, you could directly connect to the patient portal, get secure access to health records, and also share your personal health data with a care team – this is where building a habit of logging daily moods may be helpful for a provider to get a fuller picture on the state of your mental health.

GE Health says it plans to develop an AI-assisted ultrasound imaging tool that is so easy to use, that even healthcare providers without specialized training will be able to operate it. The device's research and development will be funded by a $44 million grant from the Bill & Melinda Gates Foundation, which has historically invested in the roll-out of new technologies in resource-poor settings to address gaps in healthcare access.

GE says the AI-powered imaging technology has been designed to be dispersed to low-and-middle income countries where the services of healthcare providers may be stretched thin. The ultrasound tool will be more effective at providing clear readings of lung and ultrasound scans across maternal and fetal care as well as pediatric lung health. These areas of medicine are particularly notable because maternal and child mortality is mostly preventable if medical intervention occurs early. Proper medical imaging is key to achieving timely diagnosis, guides treatment decisions and can improve treatment outcomes.

GE’s $3 billion ultrasound business, has recently focused on the development pipeline of AI software with the acquisition of med tech companies like Caption Health, which will help design this particular ultrasound device. The company appears committed to a strategy of increasing spending on AI-related projects both now and in the near future.

A new lineup of COVID-19 vaccines are now becoming available in the US. The updated shots will arrive at select pharmacies as retailers continue to receive inventory. CVS says it expects all of its pharmacies to have the new vaccines in stock by early next week, and some stores appear to already have the latest shot. Appointments at Walgreens will start opening up scheduling today, with appointments beginning for the public starting Monday.

The CDC is urging most Americans to get an updated COVID-19 vaccine, however, it does not specify if at-risk populations or immunocompromised people should get priority access. The CDC does mention that vaccination will reduce chances of “suffering the effects of Long COVID.” This CDC recommendation comes in light of an eight percent uptick in COVID-related hospitalizations this week.

Availability follows the FDA’s decision to authorize Pfizer-BioNTech’s Comirnaty and Moderna’s Spikevax shots for emergency use earlier this week. Novovax’s booster was recommended for use by the CDC, but is still awaiting emergency use authorization by the FDA. The jabs being made available are essentially updated versions of existing Moderna and Pfizer-BioNTech vaccines and that have been formulated to protect against the recent omicron subvariant called the Omicron variant XBB.1.5, the current dominant strain circulating in the US.

CDC

The CDC has also launched a Bridge Access Program, which earmarks $1 billion to ensure continued free coverage for COVID-19 vaccines to uninsured Americans.

The FDA says the timing and number of doses to get will depend on previous COVID-19 vaccines received. The FDA anticipates that COVID-19 vaccines may need to be updated annually and will likely be revised like seasonal influenza vaccines. Side effects from the vaccine may also vary from individual to individual, however the CDC notes that the most common side effects from COVID-19 vaccination include pain at the injection site, fatigue, muscle aches and headaches.

Later this week, the CDC says vaccines.gov will be updated with COVID-19 availability information as the vaccine is distributed. This government site can show which boosters are being offered at which local pharmacies using an interactive map.

Samsung’s Galaxy Watch 6 received a mostly modest upgrade from its predecessor, the Galaxy Watch 5. Sure, it may have worked to improve some health tracking features. And it even managed to give the wearable a sleeker design while extending battery life. But it is clear that Samsung was not aiming to reinvent the wheel here (and they usually don’t). It's easy to understand why too, when the last generation was already pretty good.

In this year's update, Samsung focused its efforts on expanding its wellness-centric features. These include enhanced personalized sleep coaching and insights, the ability to personalize heart rate zone training during running sessions, improved GPS tracking tailored for track runners, further customization in the workout app and the inclusion of irregular heart rate rhythm notifications, just to name a few. The caveat, of course, is that the Watch 6’s predecessors will have access to all these updates, dating back to the Watch 4. So, if you have one of the previous two models, it might not be necessary to upgrade.

Still, the Galaxy Watch 6’s modest improvements allow it to keep up with frontrunners in the field. For example, it can now stand shoulder-to-shoulder with Fitbit's advanced sleep analysis features. The new heart health tools also give the watch the EKG monitoring prowess of Apple and Pixel smartwatches. Meanwhile, the improved run coaching brings it closer to watches offered by Garmin.

Design and battery life

The mechanical bezel-free edition of the Watch 6 is priced at $299 for the 40mm model, which comes in graphite and gold; the 43mm version, which also comes in silver, commands a slightly higher price of $329. It may lack the rotating bezel of the Classic, but it does have a digital bezel which allows you to scroll through your most-used widgets like Sleep, Workouts, and Weather without needing to poke around a menu. 

With the Watch 6, Samsung also introduced a new design feature called One-Click, which makes it easier to swap bands with the literal click of a button for your ever-changing style needs. I personally am a huge fan of the graphite sports band and the flush circular face which gives the watch a sleeker feel.

The Watch 6 also boasts a more vibrant, higher-resolution display with peak brightness reaching 2,000 nits, up from the last model's max of 1,000 nits. The screen is also 20 percent larger, making it easier to read text. The always on display (AOD) drained battery life of the Watch 5 pretty quickly when our Deputy Reviews Editor Cherlynn Low reviewed it, but I didn't have similar issues wearing the Watch 6 all day.

Malak Saleh

The Galaxy Watch 6 comes equipped with a larger battery to support this year’s bigger and brighter display. Samsung claims the watch should run for up to 30 hours with the AOD on and up to 40 hours with it off. This is ideal for busy people who want the guarantee that the watch will work after an eight-hour workday before heading to the gym and again later, for sleep tracking. After using the watch for a day or two (mainly for workout tracking), I have been able to charge the watch to about 80 percent, or almost full, in under 30 minutes using the quick charge feature, adding at least another eight hours of battery life each time. However, battery life for any wearable tends to fluctuate depending on the extent of usage.

Health monitoring and tracking

Malak Saleh

The Watch 6 features an Irregular Heart Rhythm Notification (IHRN) feature, which is new for Samsung but has been around for years on competing devices. The FDA-backed IHRN tool detects EKG activity that is suggestive of atrial fibrillation (AFib), a condition that usually preempts stroke or heart failure. The feature, approved by the FDA, monitors a user's heart activity continuously in the background. Because I don't have AFib, there was no way to test this feature to see if it could accurately detect irregular heart activity. This, coupled with the traditional blood pressure monitoring, blood oxygen monitoring, body composition measuring tool, and EKG readings, add to Samsung's overall pool of individualized health data tracking that can easily be accessed in reports on a paired Android phone and shared with a healthcare provider or family member.

I do wish that after running a standard EKG reading, the language around heart health was less jargony. The "sinus rhythm detected" pop-up could easily be misunderstood, but in reality just means your heart activity is normal. That aside, Samsung did cover its own back. With each EKG cycle you run, a pop up disclosure repeats: “this wearable does not detect heart attacks.” The addition of the IHRN feature on the Watch 6 is in line with the company’s attempt to offer more useful cardiovascular insights to users.

Expanding its range of tracking features, Samsung built upon its existing menstrual cycle predictions tool introduced in the Watch 5. This includes the skin temperature reading and sensor technology from the last-gen model, which records measurements during sleep. This addition aids in monitoring your monthly period, ovulation cycle and fertility windows. For it to be useful, though, the tool needs consistent data input by a user so that its predictions get smarter.

Malak Saleh

Powered by Natural Cycles, a period tracking app, the new dedicated watch face makes it easy to input daily symptoms, which are not all necessarily tethered to a menstrual cycle. It can track everything from mood changes to physical conditions like cramping and bloating to logging sexual activity. All that data, in aggregate, can help Samsung’s app predict when a period will start and end, fertility windows, and when ovulation is expected to kick in. This is all great in theory, but if you're not great at logging daily, you might end up like me, with outdated predictions that your period was supposed to start but never did.

The new watch also comes with a fall detection feature that has a built-in SOS tool that shares a user's location with an emergency service line or emergency contact of your choosing when a hard fall is detected. You have to manually set up this feature and select when the watch should detect falls – it can be on all the time, during workouts, or quote, “during any activity, or movements not registered as exercise.” Once a fall is detected, Samsung says the device can take up to 30 seconds to recognize a fall, but the waiting period can be customized to as little as 10 seconds.

Medical information and conditions unique to a user’s health history can be plugged into the interface on the paired device. This might be especially useful for elderly populations or people who are medically at a fall risk (think post-surgical or highly medicated patients). However, during testing, after falling on different surfaces, and staying stationary for at least 30 seconds each time, I was never able to trigger the alert system. Samsung claims that after a fall, a watch should alert a user for 30 seconds with a popup, sound, and vibration. This delay is supposed to give a user time to get up or cancel the action of alerting emergency services. To be fair, this was also difficult to trigger on the competing Apple Watch Series 8.

Customizable fitness regimens

Malak Saleh

Making a unique workout plan with key metrics and goals in mind is nothing new for an avid fitness junkie. Since the launch of the Galaxy Watch 4, Samsung has made it a point to expand its workout trackers, with over 95 unique exercises and sports to track on the watch face, users can also create their own custom workouts. I regularly start my lift sessions with 45-pound dumbbells. I was able to name this workout in the watch as my deadlift warmup and keep track of the amount of calories burned per session. This focus on customization is not new, though, with competitors like Fitbit and Apple offering similar interfaces in their fitness tracking tools. The ability to create a program to burn a set amount of calories or reach a certain number of steps can be helpful for people like me who like to prefer to count down rather than up.

Continuing with the theme of customization, Samsung’s new personalized HR zones are meant to help runners better determine how fast to go. The tool is meant to allow users to keep tabs on heart rate zone data and gain insights into personal exertion levels. By staying within specific zones, I can tailor my workout to match my fitness goals, whether it's fat-burning, endurance improvement, or cardiovascular conditioning. Also, tracking heart rate can help a runner avoid overexertion, which can lead to burnout, or injury. Staying within an appropriate heart rate range ensures a runner is working out safely and sustainably. That all said, again, like most health and fitness features, the benefit of monitoring will come down to discipline. 

Malak Saleh

I put the feature to the test by setting up my personalized HR zone to a custom bracket that mimics a high-intensity performance, between 165 to 175. When I went on a run, it kept urging me to speed up and buzzed my wrist with the notification that I was below target. And these notifications are no joke. I struggled to reach my target and even when I did, it was mostly luck.

Running with that much effort, I barely had time to process how to adjust my run according to the alert. So I took a stab at the easiest HR zone target for low-intensity workouts instead at 95 to 105 bpm and found myself struggling with a similar issue-not being able to consistently stay in my target zone. This time, the HR zone alerts were constantly showering me with reminders that I was overexerting and above my HR zone. 

Malak Saleh

This is all to say that although it is a nice feature to have if you're a seasoned athlete and can comprehend and adjust your exertion accordingly. But it's almost not nearly as beneficial to just get a snapshot overview of where my HR zone naturally is with a given run tracker instead of feeling the constant distracting buzz alerting me to something I'm not sure quite sure what to do with

Overall, the notification feature is overstimulating. Even when I paused a workout and tried to have a conversation with Cherlynn, the watch kept pinging me to speed up my run, as it continued to monitor my heart rate zone activity and suggest changes even at rest. Despite this one-off, the watch’s sensitivity in terms of auto detection for movement is pretty accurate. It was noticeably faster at recognizing pauses and restarting based on my movement than my Apple Watch, which was often at least a few seconds behind.

Sleep tracking and analysis

Malak Saleh

Samsung has said it wants to enhance the sleep experience for users by expanding its comprehensive but individualized sleep pattern analysis tools since the last generation. Samsung’s previously announced Sleep Mode features, which automatically disables notifications, dims the watch's screen, and switches to an invisible infrared LED to minimize distractions. I had no trouble setting up sleep goals and (to my surprise) sleeping with the watch on. It doesn't suffocate my wrist at night and if anything, is easy to forget it's on after a while. You can also set up the Smart Things feature, which will detect when a user is sleeping and create the “ideal sleep environment” by turning off or adjusting home electronics like TVs and lights if you're connected to Samsung home devices. However, I was not able to see how the Watch 6 would interact with smart home gadgets because I don't personally own any Samsung home devices.

What I liked about the sleep analysis feature is that after each night of sleep with it on, I got a pretty comprehensive breakdown of how I slept, REM graphic and all, on the Watch 6's dedicated sleep watch face. I was able to get an even more detailed view of my sleep quality on the phone, which showed me how my nights compared on a day to day, telling me which parts of my REM graphic meant what and why it matters. For example, it broke down how much deep sleep I got and it told me how much more I needed. After sleeping with it for seven nights, you're supposed to trigger the sleep coach program that also pairs you with your “sleep animal,” a little 2D avatar that is representative of your nighttime habits. And while it was more comfortable than an Apple Watch, I just don't like the feeling of having something on my wrist at night.

The competition

The Samsung Galaxy Watch 6 has emerged as a top choice among Android users, especially at this price point. However, the Apple Watch Series 8, which starts at $399, is the obvious alternative for iPhone users. The features are similar, with both models providing GPS tracking, heart-rate sensing, fall detection, sleep tracking and automatic workout recognition.

In terms of fitness-centric offerings, the Garmin Forerunner 745, which is on sale for $299, might be better suited for athletes seeking comprehensive insights into performance metrics and running-focused training regimens. While it may not be as all-encompassing in terms of health guidance tools, it still includes fundamental features like heart rate monitoring, sleep tracking, stress monitoring, and fall detection.

But if you want pretty similar offerings in terms of fitness tracking and sleep coaching, the Fitbit Versa 4, which starts at $199, is a pretty cheap alternative. However, with the Versa 4, you get a less integrated smartwatch that feels pretty barebones. For instance, you can’t make or take phone calls or control music through the watch.

Wrap-up

Samsung has a vision for the Galaxy Watch 6 to be perceived as a health buddy, with all of its dedicated wellness-centric updates in heart health, women's health, fitness and sleep domains. But the actual benefits come down to the user. Without discipline, there are no insights to be gained, no tracking worthwhile, or coaching that will be accurate.

But this doesn't take away from the device's well-deserved shine in some areas, namely design, comfort and fitness. It's nothing we have not seen before, and if you already own a wearable of recent vintage, or are an iOS user it's probably not meant for you. If you have the last-gen Galaxy Watch, then hold on to your money because the updates are already in your pocket.

Researchers at Brigham and Women’s Hospital in Boston have developed an implant, notably as small as a grain of rice, that can test the effects of drugs on a patient’s brain tumor in real-time during surgery. Currently, monitoring the effects of drugs on a brain cancer patient during surgery is limited to intraoperative brain imaging and tissue sampling after a drug has been administered. The technique known as microdialysis currently stands as one of the more minimally invasive sampling options for testing the impact of drugs on brain tumors, but even that requires an entire catheter to be inserted into the patient’s skull cavity.

During development, researchers from Brigham and Women’s Hospital designed the device specifically to help test treatments in patients with brain cancers or gliomas, a type of tumor that originates in the brain or spinal cord. The device is designed to only remain implanted in a patient for about two to three hours while it delivers microdoses of the respective drug that is under observation. It can observe the impact of up to 20 drugs on the market for cancerous tumors, according to the researchers. Once the device is removed (sometime before the surgery ends), the surrounding tissue is returned to the lab for analysis.

In a statement published Wednesday, Pierpaolo Peruzzi, co-principal investigator and assistant professor in the Department of Neurosurgery at Brigham and Women’s Hospital said that knowing the impact of cancer drugs on these tumors is critical. “We need to be able to understand, early on, which drug works best for any given patient,” he said.

Brigham and Women’s Hospital

During the development process, researchers at the Brigham and Women’s Hospital ran a clinical trial to observe the actual impact of the implant on real patients. The study found that none of the patients in the trial experienced any adverse effects. The researchers were able to collect biological data from the devices, such as what molecular changes happened when each drug was administered. While the study demonstrated that the implant could be easily incorporated into surgical practice, the researchers are still determining how the data it can gather should be used to optimize tumor therapy.

The researchers are now conducting another study that focuses on implanting the device through a minimally invasive procedure 72 hours before their main surgery. Advancements in the cancer treatment space continue to expand, with new iterations of drug cocktails and viruses that can fight cancer cells emerging in the biotech space. Implants like the one developed by the Brigham and Women’s Hospital bring scientists one step closer to better being able to use tools and data to provide more personalized care treatment plans for cancer patients.

Researchers at Northwestern University developed a bioelectric implant that can detect temperature fluctuations that typically happen right before a body rejects an organ transplant. The sensor is smaller than a fingernail, and a mere 220 micrometers thick.

This new sensor technology is thin enough to sit directly on a kidney's fibrous layer — called the renal capsule — which surrounds and protects the organ. The device works by continuously monitoring changes to blood flow and temperature. The built-in thermometer can sense increases as minuscule as 0.004 degrees Celsius. Once an irregularity is detected, the sensor, which contains a micro coin cell battery for power, uses Bluetooth to alert a patient or physician via a smartphone or tablet. Any increase typically signals inflammation which is a potential sign of transplant rejection.

After any surgery that involves an organ transplant, the risk of rejection is high. The sensor was developed specifically for kidney transplants but it could also work for other organs, including the liver and lungs. Kidney transplants in the US are on the rise and are usually recommended for people who will not be able to live without dialysis. The American Kidney Fund cites that an acute rejection of a kidney transplant one month after surgery happens in about five to twenty percent of patients that go under.

That’s why it is critical to detect transplant rejection, which occurs when your body's immune system treats the new organ like a foreign object and attacks it. If a healthcare provider detects signs of rejection early enough, medical intervention can preserve the new organ in the new host. Northwestern researchers said that the device detected warning signs of organ rejection three weeks earlier than current monitoring methods. The current “gold standard” for detecting rejection is a biopsy, where a tissue sample is extracted from the transplanted organ and then analyzed in a lab. However, biopsies are invasive and can cause bleeding and increase the risk for infection.

Northwestern University

Despite developing an innovative first-of-its-kind product, researchers at Northwestern University still have a long way to go. It still needs to be tested on humans in a clinical setting before it can make any impact in the surgical market. Northwestern’s John A. Rogers, a bioelectronics expert who led the device development, said in a statement that his team is now evaluating ways to recharge the coin cell battery so that it can last a lifetime.

Clearblue has launched a new product that can determine what stage of menopause a person is in. The "Menopause Stage Indicator" is a urine testing device and it's the company's first for this underserved market in women's health.

The Menopause Stage Indicator looks like a standard pregnancy test stick but instead of measuring urine for pregnancy hormones, it will look for follicle-stimulating hormone (FSH) levels, which are measured to confirm menopause. To get accurate test results, you’ll have to conduct five urine tests over ten days, and Clearblue recommends they be taken every other day. Using FSH levels, menstrual cycle history, and a person’s age, the company will be able to determine and confirm the menopause stage. The app will calculate if a person is in premenopause, early perimenopause, late perimenopause, or postmenopause.

In its press release, Clearblue acknowledges that only a healthcare professional can confirm someone’s menopause stage. However, through the app, you can generate a personalized report and share it with your healthcare provider to confirm test results and discuss potential treatment options. The Menopause Stage Indicator will be available on Amazon for a starting price of $20.

Women’s health has long been cast aside as a mere subset of healthcare. And it’s even worse for aging people entering menopause. The market for a menopause testing device by Clearblue, a brand most famous for its pregnancy tests, is prime for the taking. Studies show that 73 percent of women experience menopause but do not seek treatment for their symptoms and the global menopause market size is projected to grow to $21.6 billion by 2026.

German Bionic, the robot exoskeleton startup behind the lightweight Apogee exosuit, just revealed the Apogee+, a hardware refresh intended to service health care workers. The powered exoskeleton allows nurses and other health care professionals to have greater access to patients, particularly the elderly and the infirm. The company hopes to decrease the “immense levels of stress endured” by these medical professionals.

To that end, the Apogee+ is designed as a “personal lift assistant,” providing active assistance while walking, lifting and arranging patients for treatments and sanitary procedures like showers. The robo-suit offers nearly 70 pounds of back relief per lift and includes integrated grips for getting a stable hold on things and for repositioning patients.

Just like its sibling exoskeleton, the Apogee+ is small and lightweight, so it can be worn by a variety of people in a diverse array of environments. It’s also waterproof, which should help when bathing patients, and dust-proof, which should help when, uh, working in rundown medical facilities straight out of a Stephen King novel.

Most German Bionic products, like the powerful Cray X, are designed for industrial settings, but the Apogee+ is made for health clinics, so it features a softer form factor with light “patient-friendly” colors. The suit’s unibody exterior is designed for an easy disinfection process, so germs and bacteria won’t accumulate. This is obviously quite essential in healthcare environments.

German Bionic touts recent data celebrating the efficacy of exoskeleton wearable products in the healthcare space, saying that it “offers flexible and reliable support to nursing staff.” The Apogee+ is rolling out across North America now, so it’s already available for purchase by health care entities. If you want to try it for yourself, book a passage to Germany in November. The company’s offering in-person demos at global medical trade show Medica on November 13. These exoskeletons cost $9,900 or $299 per month forr bulk purchasers.